2m 2m 2m 2m 2m 2m 2m
Liquidia (LQDA)
NASDAQ
$74.75-$0.74 (-0.97%)
Price as of Jun 23, 2026 7:54 PM EDT- $6.7BMarket Cap
- 469.31%1-Year Change
- Drug Manufacturers - Specialty & GenericIndustry
Liquidia (LQDA)
$74.75-$0.74 (-0.97%)
Annual
Quarterly
12/31/2025 | 12/31/2024 | 12/31/2023 | 12/31/2022 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | 148.3M +959.50% | 14.0M -19.97% | 17.5M +9.75% | 15.9M +23.98% | |
Cost of Revenue | 8.8M +50.09% | 5.9M +103.57% | 2.9M +1.01% | 2.9M -5.42% | |
Gross Profit | 139.5M +1,618.17% | 8.1M -44.40% | 14.6M +11.65% | 13.1M +33.02% | |
Sales and Marketing Expense | 157.2M N/A | N/A N/A | N/A N/A | N/A N/A | |
Research and Development Expense | -39.3M -17.90% | -47.8M +10.64% | -43.2M +122.50% | -19.4M -5.27% | |
Depreciation and Amortization Expense | 1.5M -30.45% | 2.2M +0.87% | 2.2M -40.28% | 3.6M -35.01% | |
Total Operating Expenses | 209.7M +55.00% | 135.3M +48.88% | 90.9M +66.11% | 54.7M +17.27% | |
Operating Profit | -51.4M -57.64% | -121.3M +65.29% | -73.4M +89.28% | -38.8M +14.71% | |
Interest Income | 6.6M -13.46% | 7.7M +120.83% | 3.5M +217.98% | 1.1M +3,160.06% | |
Interest Expense | N/A N/A | N/A N/A | -6.3M +168.31% | -2.3M +186.86% | |
Interest Income and Expense and Net | 6.6M -13.46% | 7.7M +372.68% | -2.8M +124.92% | -1.2M +59.67% | |
Total Nonoperating Income and Expense | -17.5M +92.84% | -9.1M +77.80% | -5.1M +127.97% | -2.2M +187.23% | |
Income before Taxes | -51.4M -57.64% | -121.3M +65.29% | -73.4M +89.28% | -38.8M +14.71% | |
Income Taxes | 0 N/A | 0 N/A | 0 N/A | 0 N/A | |
Extraordinary Items | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Net Income | -68.9M -47.14% | -130.4M +66.10% | -78.5M +91.40% | -41.0M +18.61% | |
Net Income from Continuing Operations Applicable to Common | -68.9M -47.14% | -130.4M +66.10% | -78.5M +91.40% | -41.0M +18.61% | |
Basic EPS and Net Income | -0.80 -51.81% | -1.66 +37.19% | -1.21 +80.60% | -0.67 -4.29% | |
Diluted EPS and Net Income | -0.80 -51.81% | -1.66 +37.19% | -1.21 +80.60% | -0.67 -4.29% | |
Basic Weighted Average Shares | 86.1M +9.34% | 78.7M +21.10% | 65.0M +6.62% | 61.0M +22.71% | |
Diluted Weighted Average Shares | 86.1M +9.34% | 78.7M +21.10% | 65.0M +6.62% | 61.0M +22.71% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 190.7M +8.05% | 176.5M +110.90% | 83.7M -10.30% | 93.3M +62.25% | |
Short-Term Investments | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash and Cash Equivalents and Short-Term Investments | 190.7M +8.05% | 176.5M +110.90% | 83.7M -10.30% | 93.3M +62.25% | |
Total Current Assets | 273.4M +47.70% | 185.1M +105.90% | 89.9M -9.93% | 99.8M +62.89% | |
Accumulated Depreciation | 14.0M -11.65% | 15.8M +3.23% | 15.3M +8.50% | 14.1M +3.91% | |
Property and Plant and Equipment and Net | 11.8M +42.73% | 8.3M +85.22% | 4.5M +7.93% | 4.2M -17.27% | |
Total Long-Term Assets | 13.2M +20.64% | 10.9M +143.71% | 4.5M +7.93% | 4.2M -17.27% | |
Total Assets | 327.9M +42.39% | 230.3M +94.63% | 118.3M -8.41% | 129.2M +37.84% | |
Income Taxes Payable | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Short-Term Debt | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Current Liabilities | 135.8M +224.95% | 41.8M +125.23% | 18.6M +110.80% | 8.8M +20.11% | |
Total Long-Term Debt | N/A N/A | N/A N/A | 19.9M 0.00% | 19.9M +90.96% | |
Total Long-Term Liabilities | 0 -100.00% | 6.9M -68.71% | 22.2M -4.45% | 23.2M +58.53% | |
Total Liabilities | 283.2M +85.04% | 153.0M +115.43% | 71.0M +83.20% | 38.8M +36.23% | |
Retained Earnings | -626.3M +11.94% | -559.5M +30.39% | -429.1M +22.39% | -350.6M +13.25% | |
Total Stockholders Equity | 44.7M -42.09% | 77.3M +63.40% | 47.3M -47.70% | 90.4M +38.54% | |
Total Shares Outstanding | 87.2M +2.98% | 84.7M +23.39% | 68.6M +6.37% | 64.5M +23.39% | |
Cash Flow | |||||
Cash from Operating Activities | -35.7M -61.80% | -93.4M +124.77% | -41.6M +45.39% | -28.6M -16.01% | |
Capital Expenditures | 4.3M -12.39% | 4.9M +283.64% | 1.3M +117.91% | 592,000 +452.14% | |
Cash from Investing Activities | -6.3M -24.94% | -8.4M -25.22% | -11.3M +1,823.00% | -587,000 +447.47% | |
Dividends Paid | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Financing Activities | 59.7M -69.32% | 194.7M +350.11% | 43.2M -33.43% | 65.0M +146.82% | |
Financials Ratio | |||||
Gross Margin | 94.05% +62.17% | 58.00% -30.53% | 83.49% +1.74% | 82.06% +7.29% | |
Operating Margin | -34.65% -96.00% | -866.63% +106.53% | -419.62% +72.47% | -243.30% -7.47% | |
Return on Assets | -24.69% -66.99% | -74.80% +17.93% | -63.43% +72.37% | -36.80% +2.83% | |
Return on Equity | -112.97% -46.04% | -209.35% +83.63% | -114.01% +116.38% | -52.69% +3.88% | |
Revenue Growth | 959.50% +4,905.20% | -19.97% -304.89% | 9.75% -59.35% | 23.98% -98.54% | |
Current Ratio | 2.01 -54.55% | 4.43 -8.58% | 4.85 -57.27% | 11.34 +35.62% | |
Cash Ratio | 1.40 -66.75% | 4.22 -6.36% | 4.51 -57.44% | 10.60 +35.09% | |
Debt-to-Equity Ratio | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Debt-to-Assets Ratio | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow